Chemoinformaics analysis of LIMONOATE-A-RING-LACTONE
| Molecular Weight | 488.533 | nRot | 3 |
| Heavy Atom Molecular Weight | 456.277 | nRig | 31 |
| Exact Molecular Weight | 488.205 | nRing | 6 |
| Solubility: LogS | -4.155 | nHRing | 4 |
| Solubility: LogP | 1.831 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 67 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 5 |
| nHA | 8 | APOL | 71.9754 |
| nHD | 2 | BPOL | 41.6506 |
| QED | 0.486 |
| Synth | 6.22 |
| Natural Product Likeliness | 3.166 |
| NR-PPAR-gamma | 0.915 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.03 |
| Pgp-sub | 0.04 |
| HIA | 0.335 |
| CACO-2 | -5.506 |
| MDCK | 0.0000594 |
| BBB | 0.978 |
| PPB | 0.73955 |
| VDSS | 0.502 |
| FU | 0.285747 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.262 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.694 |
| CYP2c9-inh | 0.016 |
| CYP2c9-sub | 0.062 |
| CYP2d6-inh | 0.022 |
| CYP2d6-sub | 0.133 |
| CYP3a4-inh | 0.058 |
| CYP3a4-sub | 0.176 |
| CL | 12.112 |
| T12 | 0.306 |
| hERG | 0.003 |
| Ames | 0.046 |
| ROA | 0.988 |
| SkinSen | 0.014 |
| Carcinogencity | 0.897 |
| EI | 0.155 |
| Respiratory | 0.981 |
| NR-Aromatase | 0.522 |
| Antiviral | Yes |
| Prediction | 0.81665 |